Determination of digoxin and digitoxin in whole blood

Journal of Analytical Toxicology

Volumn 33, Issue 7, 2009, Pages 372-378

  Øiestad, Elisabeth Leere ^a,c   Johansen, Unni ^a   Opdal, Mimi Stokke ^b   Bergan, Stein ^c   Christophersen, Asbjørg Solberg ^a  

^a NORWEGIAN INSTITUTE OF PUBLIC HEALTH   (Norway)

^b ULLEVÅL UNIVERSITY HOSPITAL   (Norway)

^c OSLO UNIVERSITY HOSPITAL   (Norway)

Author keywords

[No Author keywords available]

Indexed keywords

ACETIC ACID ETHYL ESTER; DICHLOROMETHANE; DIGITOXIN; DIGOXIN; HEPTANE;

ACCURACY; ARTICLE; AUTOPSY; BLOOD SAMPLING; CALIBRATION; HUMAN; LIQUID CHROMATOGRAPHY; LIQUID LIQUID EXTRACTION; POSITIVE ION ELECTROSPRAY; TANDEM MASS SPECTROMETRY; TIME; VALIDATION PROCESS;

EID: 70349276790     PISSN: 01464760     EISSN: 01464760     Source Type: Journal    
DOI: 10.1093/jat/33.7.372     Document Type: Article

References (26)

1. Goodman & Gilman's The Pharmacological Basis of Therapeutics. McGraw-Hill, New York, NY, 2001.
2. R.A. Kelly and T.W. Smith. Recognition and management of digitalis toxicity. Am. J. Cardiol. 69: G108-G119 (1992).
3. J. Tamargo, E. Delpon, and R. Caballero. The safety of digoxin as a pharmacological treatment of atrial fibrillation. Expert Opin. Drug Saf. 5: 453-467 (2006).
4. The Digitalis Investigation Group. The effect of digoxin on mortality and morbidity in patients with heart failure. N. Engl. J. Med. 336: 525-533 (1997).
5. A. Ahmed, M.W. Rich, T.E. Love, D.M. Lloyd-Jones, I.B. Aban, W.S. Colucci, K.F. Adams, and M. Gheorghiade. Digoxin and reduction in mortality and hospitalization in heart failure: a comprehensive post hoc analysis of the DIG trial. Eur. Heart J. 27: 178-186 (2006).
6. S.S. Rathore, J.P. Curtis, Y. Wang, M.R. Bristow, and H.M. Krumholz. Association of serum digoxin concentration and outcomes in patients with heart failure. J. Am. Med. Assoc. 289: 871-878 (2003).
7. T. Skolmedal, J.-B. Osnes, and Norsk Cardiologisk Selskaps arbeidsgruppe for hjertesvikt. Change in recommended therapeutic serum concentration range for digoxin and digitoxin. Hjerteforum 20: 27-31 (2007) (in Norwegian).
8. P. Datta and S.W. Graves. Patients with suspicious digoxin levels: evaluation of the potential contribution of crossreactive digoxin metabolites. Clin. Biochem. 31: 51-54 (1998).
9. W. Steimer, C. Muller, B. Eber, and K. Emmanuilidis. Intoxication due to negative canrenone interference in digoxin drug monitoring. Lancet 354: 1176-1177 (1999).
10. R. Valdes and S.A. Jortani. Unexpected suppression of immunoassay results by cross-reactivity: now a demonstrated cause for concern. Clin. Chem. 48: 405-406 (2002).
11. E. Lacassie, P. Marquet, S. Martin-Dupont, J.M. Gaulier, and G. Lachatre. A non-fatal case of intoxication with foxglove, documented by means of liquid chromatography-electrospray-mass spectrometry. J. Forensic Sci. 45: 1154-1158 (2000).
12. A. Salvador, C. Sagan, and J. Denouel. Rapid quantitation of digoxin in human plasma and urine using isotope dilution liquid chromatography-tandem mass spectrometry. J. Liq. Chromatogr. Rel. Technol. 29: 1917-1932 (2006).
13. S.R.C.J. Santos, W. Kirch, and E.E. Ohnhaus. Simultaneous analysis of digitoxin and its clinically relevant metabolites using high-performance liquid chromatography and radioimmunoassay. J. Chromatogr. 419: 155-164 (1987).
14. A. Tracqui, P. Kintz, B. Ludes, and P. Mangin. High-performance liquid chromatography-ionspray mass spectrometry for the specific determination of digoxin and some related cardiac glycosides in human plasma. J. Chromatogr. B Biomed. Sci. Appl. 692: 101-109 (1997).
15. M.-C. Tzou, R.A. Sams, and R.H. Reuning. Specific and sensitive determination of digoxin and metabolites in human serum by high performance liquid chromatography with cyclodextrin solid-phase extraction and precolumn fluorescence derivatization. J. Pharm. Biomed. Anal. 13: 1531-1540 (1995).
16. M. Yao, H. Zhang, S. Chong, M. Zhu, and R.A. Morrison. A rapid and sensitive LC/MS/MS assay for quantitative determination of digoxin in rat plasma. J. Pharm. Biomed. Anal. 32: 1189-1197 (2003).
17. Y. Hashimoto, K. Shibakawa, S. Nakade, and Y. Miyata. Validation and application of a 96-well format solid-phase extraction and liquid chromatography-tandem mass spectrometry method for the quantitation of digoxin in human plasma. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 869: 126-132 (2008).
18. K. Mitamura, A. Horikawa, Y. Yamane, Y. Ikeda, Y. Fuji, and K. Shimada. Determination of digoxin in human serum using stable isotope dilution liquid chromatography/electrospray ionization-tandem mass spectrometry. Biol. Pharm. Bull. 30: 1653-1656 (2007).
19. B.J. Kirby, T. Kalhorn, M. Hebert, T. Easterling, and J.D. Unadkat. Sensitive and specific LC-MS assay for quantification of digoxin in human plasma and urine. Biomed. Chromatogr. 22: 712-718 (2008).
20. S. Shi, Z. Li, H. Chen, and F. Zeng. Development and validation of an LC-MS method with electrospray ionization for quantitation of digoxin in human plasma and urine: application to a pharmacokinetic study. J. Chromatogr. B Analyt. Technol. Biomed. Life Sci. 875: 405-410 (2008).
21. F.Y. Guan, A. Ishii, H. Seno, K. Watanabe-Suzuki, T. Kumazawa, and O. Suzuki. Identification and quantification of cardiac glycosides in blood and urine samples by HPLC/MS/MS. Anal. Chem. 71: 4034-4043 (1999).
22. L. Frommherz, H. Kohler, B. Brinkmann, M. Lehr, and J. Beike. LC-MS assay for quantitative determination of cardio glycoside in human blood samples. Int. J. Legal Med. 122(2): 109-114 (2008).
23. Commission Decision of 12 August 2002 implementing Council Directive 96/23/EC concerning the performance of analytical methods and the interpretation of results. Commission EU, 2002/657/EC. Off. J. Eur. Communities L Legis. 221: 8-36 (2002).
24. B.K. Matuszewski, M.L. Constanzer, and C.M. Chavez-Eng. Strategies for the assessment of matrix effect in quantitative bioanalytical methods based on HPLC-MS/MS. Anal. Chem. 75: 3019-3030 (2003).
25. Digitoxin. Abbott Laboratories 2005. http://www.abbottdiagnos tics.com/webapp/index.cfm?event=getPDF&controlNumber=343 885.
26. Digoxin II. Abbott Laboratories 2008. http://www.abbottdiagnos tics.com/webapp/index.cfm?event=getPDF&controlNumber=344 996R8.